(Q44233599)

1 December 2017

title

Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being (English)

1 reference

1 December 2017

1 reference

3

1 reference

1 December 2017

5

1 reference

1 December 2017

Sussanne Börjeson

1

1 reference

1 December 2017

Timo J Hursti

series ordinal

2

1 reference

1 December 2017

Curt Peterson

series ordinal

4

1 reference

1 December 2017

publication date

1 September 2002

1 reference

Journal of Pain and Symptom Management

1 December 2017

published in

1 reference

1 December 2017

volume

24

1 reference

1 December 2017

issue

3

1 reference

1 December 2017

page(s)

345-358

1 reference

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Quality of life consequences of chemotherapy-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Subjective well-being.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Psycho-oncology: psychological well-being as one component of quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Measurement of the quality of life in cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Quality of life assessment in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Cancer-specific quality of life questionnaires: the state of the art in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Assessment of the quality of life of patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Single high-dose dexamethasone improves the effect of ondansetron on acute chemotherapy-induced nausea and vomiting but impairs the control of delayed symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Applied relaxation: description of a coping technique and review of controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Impact of nausea/vomiting on quality of life as a visual analogue scale-derived utility score

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Quality of life studies in chemotherapy-induced emesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

A randomized clinical trial of home nursing care for lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Quality-of-life assessment in a home care program for advanced cancer patients: a study using the Symptom Distress Scale

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Nursing as the promotion of well‐being: the client's experience

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

The role of information in patients' adaptation to chemotherapy and radiotherapy: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Metoclopramide. An updated review of its pharmacological properties and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Side effects and emotional distress during cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

A definition of bias founded on the concept of the study base.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

A comprehensive clinical epidemiological theory based on the concept of the source person-time and four distinct study stages

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Efficacy of relaxation training and guided imagery in reducing the aversiveness of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900543-2

7 January 2021

10.1016/S0885-3924(02)00543-2

Identifiers

DOI

1 reference

1 December 2017

1 reference